

Healthcare Collapse (91)Is the Approval of Meiji HD's "KOSTAIVE" Compensation for Cleaning up the Kaketsuken Scandal?
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The COVID-19 vaccine KOSTAIVE, developed by Meiji Seika Pharma, a subsidiary of Meiji Holdings (Meiji HD), is drawing public attention. Social media is overflowing with rumors such as false claims that "shedding from vaccinated individuals can infect others around them." Shedding refers to the idea that after KOSTAIVE proliferates in the recipient’s body, some of it is released into the
Aug 17, 2025


Changing topics, choose and tell―Radiation Classroom
Masaharu Tsubokura, M.D., Ph.D. Chief Professor, Department of Radiation Health Management, School of Medicine, Fukushima Medical...
Aug 3, 2025


推进儿科医疗的在线诊疗
医疗管理研究所理事长 上 昌广 ● 63%的在线诊疗用户是儿科患者。 在新冠疫情中,医疗将如何改变呢?我关注的是在线诊疗的普及,特别是儿科似乎很适合。 2023年1月,美国斯坦福大学的医生们在《家庭医学会刊》上报告说,对12-18岁患者的诊疗有43%是通过在线问诊完成的。...
Jul 11, 2025


Heatstroke Prevalence and Prevention in Fukushima
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan From May 25 to 27, the traditional festival of...
Jun 22, 2025


日本娱乐圈丑闻与打破沉默:不当行为、#MeToo 与世代变革
谷本哲也博士 围绕52岁前媒体人物中居正广的争议,已在日本娱乐及广播行业引发重动荡。中居正广曾是男子偶像组合SMAP的成员,他被指控在2023年6月的一次晚餐中,对一名20多岁的富士电视台女员工实施性侵犯。据报道,他与该女子达成庭外和解,支付了9000万日元(约合人民币42...
May 10, 2025


Medication or Fasting? A Scientific Perspective on Modern Obesity Treatment
By: Tetsuya Tanimoto, MD Chairman of Accessible Railway Medical Services Tetsuikai Medical Corporation Director of Navitas Clinic Kawasaki In the ever-evolving world of metabolic health management, we stand at a peculiar, almost mystical crossroads. On one side, a line-up of cutting-edge pharmaceuticals, the stars of which are GLP-1 receptor agonists, have appeared, almost from thin air. These drugs—sleek, precise, and modern—promise a life free from constant hunger and the w
Apr 25, 2025


The Shadow of Vaccines Revealed by the Costaive Controversy: Lessons for the Future on Establishing Safety Evaluations
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan The new coronavirus vaccine "Costaive," developed by Meiji Seika Pharma (a subsidiary of Meiji Holdings), has garnered significant public attention. Social media is flooded with misinformation, including claims that vaccinated individuals can infect others through 'shedding'. Meiji has initiated defamation lawsuits against anti-vaccine groups that have led the spread of these falsehoods.
Apr 6, 2025


Pharmaceutical Economics Column: Exploring the Economics of Medications (Part 142)Potentially Inappropriate Prescribing in Ireland
Tetsuya Tanimoto, M.D. Medical Governance Research Institute, Tokyo, Japan In spring 2023, our pharmaceutical conflicts of interest research group participated in an international conference in Bath, UK. There, we had the pleasure of meeting Professor Tom Fahey from the Royal College of Surgeons in Ireland. While Ireland is a small nation with an estimated population of 5.28 million in 2023, it boasts a young demographic and impressive economic metrics. According to the IMF,
Mar 28, 2025


選擇並交流不斷變化的主題
福岛医科大学放射健康管理系教授 坪仓正治 這是該系列的第500版,自发表至今已近10年了。向一直以來支持我們的大家,以及每週都在截止日期前工作到最後一刻的編輯部的各位,表示衷心的感謝。 與10年前相比,縣民需要获取的资讯和关心的興趣發生了變化,縣外談論的有關輻射的資訊也發生...
Mar 28, 2025


Medical Renaissance54. Japan is 20 years behind the United States - The Beni-Koji (red yeast rice) issue is a good opportunity to think about the state of Japanese society.
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan Anything made by humans cannot eliminate the...
Mar 14, 2025


Thoughts from a doctor whose grandparents have dementia.Does the herpes zoster vaccine lower the risk? Research publications continue to emerge.
Kana Yamamoto, M.D., Ph.D Physician, Medical Governance Research Institute The Japan Meteorological Agency (※1) announced on August 1st...
Feb 14, 2025


Lasker Award and GLP-1
Accessible Rail Medical Services Tetsuikai, Navitas Clinic Kawasaki, Tetsuya Tanimoto, MD GLP-1 receptor agonists are very popular around...
Jan 31, 2025


Reviewing the Fukushima Prefectural Ohno Hospital Incident(2/2)
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan However, this incident occurred in Fukushima, Mr. Munakata's home prefecture. Perhaps he had an interest due to it being about his hometown. He said, "Since a junior asked," and introduced me to an excellent female staff member. She came to the medical research lab at Tokyo University and spent about two hours listening to the situation. After hearing my explanation, she said, "It's not
Jan 17, 2025


Reviewing the Fukushima Prefectural Ohno Hospital Incident(1/2)
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan I recently had the opportunity to revisit the 2006 arrest incident of an obstetrician at Fukushima Prefectural Ohno Hospital. This was due to assisting Yuria Iyano, a student from Yokohama City University Medical School, with her report. Ms. Iyano chose to study under Professor Suzuki at the Graduate School of Public Policy, University of Tokyo, as part of her external training curriculu
Dec 25, 2024


"Cancer Before Age 49" Increases by 80% Over 30 Years: Revealing Why Younger Cancer Patients Are On the Rise Globally
Mutsuko Ohnishi, MD, Internal medicine physician in Boston, USA Researchers from Harvard University reported in September last year that...
Nov 22, 2024




















